Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-39,458
Closed -$2.11M 84
2014
Q4
$2.11M Buy
39,458
+920
+2% +$51.5K 0.31% 61
2014
Q3
$2.21M Buy
38,538
+1,633
+4% +$100K 0.33% 61
2014
Q2
$2.47M Sell
36,905
-82,431
-69% -$5.58M 0.37% 60
2014
Q1
$7.97M Buy
119,336
+1,205
+1% +$81.5K 1.13% 44
2013
Q4
$7.88M Buy
118,131
+2,613
+2% +$169K 1.12% 45
2013
Q3
$7.25M Sell
115,518
-2,831
-2% -$182K 1.13% 43
2013
Q2
$7.39M Buy
+118,349
New +$7.51M 1.29% 38

Other funds holding GSK

S&T Bank's GSK Position: Q1 2015 in Review

S&T Bank sold out of GSK (GSK) in Q1 2015, closing a stake of 39,458 shares — an estimated $2.11M sold.

S&T Bank first reported a position in GSK in Q2 2013 and held it in 7 quarters. The position peaked at $7.97M in Q1 2014. 740 funds tracked by Wall St. Rank hold GSK as of Q1 2015.

  • S&T Bank reported no remaining GSK position as of Q1 2015 after selling out during the quarter.
  • S&T Bank sold 39,458 GSK shares in Q1 2015, an estimated $2.11M.
  • S&T Bank first reported a position in GSK in Q2 2013 and held it in 7 quarters.
  • S&T Bank's GSK position peaked at $7.97M in Q1 2014.
  • 740 funds tracked by Wall St. Rank held GSK as of Q1 2015.

Based on S&T Bank's 13F filing for Q1 2015, filed 15 May 2015.